Brewis Neil 4
4 · F-star Therapeutics, Inc. · Filed Mar 11, 2021
Insider Transaction Report
Form 4
Brewis Neil
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2021-03-09+22,561→ 99,180 totalExercise: $7.24Exp: 2021-03-09→ Common Stock (22,561 underlying)
Footnotes (2)
- [F1]These options were granted under the Issuer's 2015 Equity Incentive Plan.
- [F2]Twenty five percent (25%) of the total number of shares under the award shall vest on the first anniversary of the Vesting Commencement Date, March 9, 2021, and thereafter in equal monthly installments over the remaining three years.